Brazil's Regulation: Resolution of the ANVISA Collegiate Board No. 1018, of March 6, 2026: Amends Collegiate Board Resolution No. 977, of June 5, 2025, Which Provides for ANVISA's Administrative Control in Foreign Trade Operations of Goods and Products Su
Amendments to ANVISA’s administrative rules governing foreign trade of health-regulated goods and products.
ANVISA | Pharmaceuticals | Country Regulatory AffairsANVISA Expands Project to Reduce Review Queues for Biological Products
ANVISA expanded its initiative to reduce regulatory backlog for biological products, aiming to improve timelines and increase efficiency in product evaluations.
ANVISA | Pharmaceuticals | Country Regulatory AffairsANVISA Introduces Solicita Profile for Fee Payment Management
ANVISA implemented a new Solicita system profile focused on fee payments, improving financial processing and submission management within regulatory workflows.
ANVISA | Pharmaceuticals | Country Regulatory AffairsANVISA Resolution 1018/2026 Updates Foreign Trade Regulatory Control Framework
ANVISA amended RDC 977/2025 through Resolution 1018/2026, strengthening administrative control over foreign trade operations involving health-regulated products.
ANVISA | Pharmaceuticals | Country Regulatory AffairsNew Subject Code Introduced for Bioequivalence Study Petitions
ANVISA introduced a new subject code for petitions related to bioequivalence studies, improving submission categorization and regulatory processing efficiency.
ANVISA | Pharmaceuticals | Country Regulatory Affairs
Consult
